Navigation Links
The Court Supports Bavarian Nordic's Decision to Start Patent Infringement Case Against Oxford BioMedica
Date:5/9/2009

formation that is not historical information. We undertake no obligation to publicly update or revise forward-looking statements to reflect subsequent events or circumstances after the date made, except as required by law.

About Bavarian Nordic

Bavarian Nordic A/S is a leading industrial biotechnology company developing and producing novel vaccines for the treatment and prevention of life-threatening diseases with a large unmet medical need. The company's business strategy is focused in three areas: biodefence, cancer and infectious diseases. Bavarian Nordic's proprietary and patented technology MVA-BN(R) is one of the world's safest, multivalent vaccine vectors. Bavarian Nordic has ongoing contracts with the US government for the late-stage development and procurement of the company's third-generation smallpox vaccine, IMVAMUNE(R).

Bavarian Nordic is listed on NASDAQ OMX Copenhagen under the symbol BAVA.

For more information please visit http://www.bavarian-nordic.com


'/>"/>
SOURCE Bavarian Nordic A/S
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
2. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
3. Forest Laboratories Announces Federal Appeals Court Upholds Lexapro(R) Patent Decision
4. Agencourt Genomic Services is Key Collaborator in New Research That Further Defines Landscape of Breast and Colon Cancers
5. U.S. District Court Decision About Eisais Legal Action Over Aricept ODT(R) ANDA Filing
6. Delaware Court Denies Motion by SIGA Technologies Seeking to Dismiss PharmAthenes Legal Action in Breach of Contract Lawsuit Against SIGA
7. AstraZeneca Response to February 21, 2008 Ruling In Re: Alabama Medicaid Pharmaceutical AWP Litigation - cv2005-219 - Circuit Court of Montgomery, Alabama
8. Results of Court Meeting and Extraordinary General Meeting - Shareholders Approve Scheme of Arrangement and New Share Plans
9. Retired Supreme Court Justice Sandra Day OConnor and Former House Speaker Newt Gingrich Address Senate Special Committee on Aging, Calling for Urgent Action Against Alzheimers Disease
10. Court Determines that University of Pittsburgh and Artecel Have Sole Rights to Adipose-Derived Stem Cell Patent
11. Concerned Shareholders of Biovail seek court order declaring Biovail AGM illegally convened;

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/5/2009)... ThermoGenesis Corp. (Na...oducts for processing and storing adult stem cells...fiscal 2010. ,, For the quarter ended September...illion, a 15 percent increase over revenues of $4....pany said the key contributors to the growth in re...
(Date:11/5/2009)...wire-FirstCall/ -- BioSpecifics Technologies Corp....eloping first-in-class collagenase-based products,...rd quarter ended September 30, 2009. ,, "We we..., the FDA,s Arthritis Advisory Committee unanimous... XIAFLEX(TM) for the treatment of Dupuytren,s dise...
(Date:11/5/2009)...9 Senomyx, Inc. (Nasdaq:...aste receptor-based technologies to discover novel...gredient supply industries, today provided a corpo... third quarter ended September 30, 2009. Revenues...compared to $4.0 million for the third quarter of ...
(Date:11/5/2009).... 5 /PRNewswire-Asia-FirstCall/ -- BMP Sunstone,Co..."Company") today announced,that the Company plans ...,Monday, November 9, 2009, after the market closes...ll at 5:00 pm ET on November 9, 2009,to discuss th...e call by,dialing 1-888-713-4211 or 1-617-213-4864...
Breaking Biology Technology:ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 2ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 3ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 4ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 5ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 6ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 7ThermoGenesis Reports 15 Percent Increase in First Quarter Revenues; Improved Bottom Line 8BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 2SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 3SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 4SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 5SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 6SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 7SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 8SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 9SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 10SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 11SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 12SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 13SENOMYX ANNOUNCES CORPORATE UPDATE AND THIRD QUARTER 2009 FINANCIAL RESULTS 14BMP Sunstone to Report Third Quarter 2009 Financial Results 2
...s. - Quintessence Biosciences , a biopharmaceuti...nced that QB139, one of its EVade cancer treatment...uman clinical trials. , ,Quintessence said that p...it would submit to the U.S. Food and Drug Adminis...n late 2007, with human clinical trials expected t...
..., Wis. - Five years removed from the dotcom bubbl...investors and questioning the value of the online ...ractive are emerging. The models are both progress... traditional in their adherence to financial reali... made clearer by a panel of Internet entrepreneurs...
...Wis. - If you dropped the word sustainability in ...t of them would have pegged you as an aging hippie...riding their bikes to work. , ,Today, sustainabili...e same business execs might stick around to talk b.... Global climate change, constraints on some resou...
Other Biology Technology:Web-centric entrepreneurs find models that attract investment 2Web-centric entrepreneurs find models that attract investment 3Web-centric entrepreneurs find models that attract investment 4Web-centric entrepreneurs find models that attract investment 5Re-engineering our economy to be sustainable and profitable 2Re-engineering our economy to be sustainable and profitable 3Re-engineering our economy to be sustainable and profitable 4
(Date:11/4/2009)...ncoe Software, Inc., the commercial arm of the Ope...//openmicroscopy.org ), is proud to announce its ...ology,s exciting new project titled "The Cell: An ...stimulus grant through the National Institutes of ...t of the American Reinvestment and Recovery Act, t...
(Date:11/3/2009)... For more than 25 years, all attempts at culturing...ve been unsuccessfuluntil now. For the first time,...ce beaded (nucleated) and non-beaded cultured pear...entists from Florida Atlantic University,s Harbor ...han two years of research and experimentation, Drs...
(Date:11/3/2009)...ublished in a recent issue of HortTechnology , sc...he effects of covering orchard floors with reflect...ght distribution, orchard temperature, and profita...day and Solarmate films installed 5 weeks before c...ples. The research showed that the use of both fil...
Breaking Biology News(10 mins):Glencoe Software to Support the ASCB 'Stimulus Grant' to Build Virtual Image Library of the Cell 2Scientists are first to 'unlock' the mystery of creating cultured pearls from the queen conch 2Scientists are first to 'unlock' the mystery of creating cultured pearls from the queen conch 3Reflective film can boost profits for apple growers 2Penn studies point to strategies for reducing painful breast cancer drug side effects 58396 1Penn studies point to strategies for reducing painful breast cancer drug side effects 58396 2Penn studies point to strategies for reducing painful breast cancer drug side effects 58396 3UC nanotech researchers develop artificial pore 10127 1UC nanotech researchers develop artificial pore 10127 2Sogeti USA Grows to Ensure Industry Expertise for Clients 58394 1Sogeti USA Grows to Ensure Industry Expertise for Clients 58394 2Sogeti USA Grows to Ensure Industry Expertise for Clients 58394 3
... Mammalian skin requires constant maintenance, but... what rate? In the March 23, 2009 issue of the Jo...ues reveal that skin fibroblasts use a protein cal...elial cells don,t proliferate too quickly. Their r...ent cell types are critical to maintain the skin a...
..., BETHESDA, Md. (March 23, 2009) We are used to th...ctors or lifestyle choices, such as what we eat an...eart disease: breathing. , Accumulating evidence ...ution is associated with an increase in heart atta...ly new field of environmental cardiology -- a fiel...
..., A ghostly property of matter, called quantum tun...enomic sequencing, according to a new paper in Na... his collaborators at the Biodesign Institute of A...particle, say an electron, can cross a barrier, wh...ve enough energy to do so. , Unraveling the DNA s...
Other Biology News:Time (and PPAR-beta/delta) heals all wounds 2Time (and PPAR-beta/delta) heals all wounds 3Inhaling a heart attack: How air pollution can cause heart disease 2Inhaling a heart attack: How air pollution can cause heart disease 3Covering the bases: Quantum effect may hold promise for low-cost DNA sequencing, sensor applications 2Covering the bases: Quantum effect may hold promise for low-cost DNA sequencing, sensor applications 3Covering the bases: Quantum effect may hold promise for low-cost DNA sequencing, sensor applications 4
Solvent-Detergent Removal Resin from Sigma-Aldrich
Nunc OmniTray from Sigma-Aldrich
...tomated systems for a broad range of applications....ing from compound logistics, over screening to mol...which means it has fully automated primary screen,... studies all at your fingertips. The systems are ...
...perience in providing versatile liquid handling pl...tform delivers even more flexibility and possibili...ther with the new easy-to-use software, Freedom EV...rate genomics, proteomics, and drug discovery appl...
Biology Products: